Pilot study of losartan for pulmonary hypertension in chronic obstructive pulmonary disease
<p>Abstract</p> <p>Background</p> <p>Morbidity in COPD results from a combination of factors including hypoxia-induced pulmonary hypertension, in part due to pulmonary vascular remodelling. Animal studies suggest a role of angiotensin II and acute studies in man concur....
Main Authors: | Shakur B Haleema, Phillips Peter G, Higham Matthew A, Morrell Nicholas W, Robinson Paul J, Beddoes Ray J |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2005-08-01
|
Series: | Respiratory Research |
Online Access: | http://respiratory-research.com/content/6/1/88 |
Similar Items
-
Clinical insights into pulmonary hypertension in chronic obstructive pulmonary disease
by: Daniel P. Cook, et al.
Published: (2022-01-01) -
Impact of obstructive sleep apnea on pulmonary hypertension in patients with chronic obstructive pulmonary disease
by: Wan-Lu Sun, et al.
Published: (2019-06-01) -
The role of vitamin D in chronic obstructive pulmonary disease with pulmonary hypertension
by: Mengxi Li
Published: (2023-10-01) -
Effect of bosentan upon pulmonary hypertension in chronic obstructive pulmonary disease
by: Giuseppe Valerio, et al.
Published: (2009-02-01) -
Evaluation of exercise capacity in chronic obstructive pulmonary disease patients with pulmonary hypertension
by: Ashraf Z E-A Mohamed, et al.
Published: (2024-01-01)